Gary P. Wormser, M.D.

Chief of the Division of Infectious Diseases, Vice Chairman of the Department of Medicine

Professor of Medicine, Microbiology & Immunology, and Pharmacology

Department of Medicine\nMicrobiology & Immunology\nPharmacology

New York Medical College

Gary P. Wormser is a professor of medicine and pharmacology, chief of the Division of Infectious Diseases, vice chairman of the Department of Medicine and director of the Lyme Disease Diagnostic Center at New York Medical College. He earned his undergraduate degree from the University of Pennsylvania and his M.D. from the Johns Hopkins University School of Medicine. He leads a top team of experts in the study of tick-borne diseases, including Lyme disease, anaplasmosis and babesiosis. His interest in infectious diseases dates back to 1981 when he and colleagues wrote the first paper on AIDS to appear in a scientific journal, and he has spoken on the use of smallpox and other deadly viruses as bioterrorist weapons.

Areas of Expertise

Infectious disease, Lyme disease, bio-threats, medicine, pharmacology, microbiology and immunology, lyme disease, babesiosis, human granulocytic anaplasmosis

Education

  • BS, University of Pennsylvania
  • MD, Johns Hopkins University School of Medicine
  • Residency, Internal Medicine, Icahn School of Medicine at Mount Sinai 
  • Residency, Internal Medicine, NYC Health + Hospitals/Elmhurst

Publications

  • Ogrinc K, Bogovič P, Rojko T, et. al. "Proportion of confirmed Lyme neuroborreliosis cases among patients with suspected early European Lyme neuroborreliosis." Research square, (), (2024) . pii: rs.3.rs-5231881. doi: 10.21203/rs.3.rs-5231881/v1
  • Ogrinc K, Bogovič P, Rojko T, et. al. "Proportion of confirmed Lyme neuroborreliosis cases among adult patients with suspected early European Lyme neuroborreliosis." Infection, (), (2025) . doi: 10.1007/s15010-024-02461-0
  • Wormser GP, Zentmaier L, Liveris D, et. al. "Antibodies to Anaplasma phagocytophilum in Patients with Human Granulocytic Anaplasmosis Confirmed by Both Polymerase Chain Reaction and Culture." The American journal of medicine, (), (2024) . pii: S0002-9343(24)00778-2. doi: 10.1016/j.amjmed.2024.11.025
  • Wormser GP, Schneider LM, Joseph JT, et. al. "Surveillance data from 2011-2020 indicate a lower risk of Lyme disease in the USA in even-numbered years." Wiener klinische Wochenschrift, 136(21-22), (2024) 636-638. doi: 10.1007/s00508-024-02452-z
  • Aguero-Rosenfeld ME, Zentmaier L, Liveris D, et. al. "Culture and other direct detection methods to diagnose human granulocytic anaplasmosis." American journal of clinical pathology, (), (2024) . pii: aqae126. doi: 10.1093/ajcp/aqae126
  • Maraspin V, Ogrinc K, Bogovič P, et. al. "Erythema Migrans in Patients with Post-Traumatic Splenectomy." Microorganisms, 12(7), (2024) . doi: 10.3390/microorganisms12071465
  • Ben Mamoun C, Wormser GP. "Reply to Dow and Smith." The Journal of infectious diseases, 230(1), (2024) 273. doi: 10.1093/infdis/jiae194
View All Publications

In The News

Major test of first possible Lyme vaccine in 20 years begins, The Journal Record


These are the top doctors in Westchester County in 2021, Westchester Magazine


Lyme disease, Fibromylagia link evaporates, MedPage Today